Drugs Made In America Acquisition Corp. (DMAAR) › Operating IncomeDrugs Made In America Acquisition Corp. (DMAAR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.Fiscal YearOperating IncomeChange YoY2025-$2.82M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share